{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:06:27Z","timestamp":1761509187310,"version":"build-2065373602"},"reference-count":25,"publisher":"CSIRO Publishing","issue":"3","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":3055,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,5]]},"abstract":"<jats:p>Neisseria gonorrhoeae has a remarkable ability to develop resistance to all available therapeutic antimicrobials. This report describes the first four cases of verified failure to treat gonorrhoea using 1000 mg cefathiamidine intramuscularly in Guangzhou, China; for each case, the patient was clinically cured after treatment with 500 mg ceftriaxone intramuscularly. Enhanced monitoring of clinical treatment failures, finding new effective treatments and updating treatment guidelines are all of utmost importance to curb the spread of drug-resistant gonorrhoea.<\/jats:p>","DOI":"10.1071\/sh16087","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T19:20:27Z","timestamp":1491506427000},"page":"289-292","source":"Crossref","is-referenced-by-count":0,"title":["First four failures of cefathiamidine to treat urogenital gonorrhoea in Guangzhou, China, 2014\u201315"],"prefix":"10.1071","volume":"14","author":[{"given":"Jingyao","family":"Liang","sequence":"first","affiliation":[{"name":"AInstitute of Dermatology, Guangzhou Medical University, Guangzhou 510095, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"BDepartment of Dermatology, Guangzhou Institute of Dermatology, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"CThese two authors contributed equally to this work."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ridong","family":"Yang","sequence":"additional","affiliation":[{"name":"AInstitute of Dermatology, Guangzhou Medical University, Guangzhou 510095, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"BDepartment of Dermatology, Guangzhou Institute of Dermatology, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"CThese two authors contributed equally to this work."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[{"name":"AInstitute of Dermatology, Guangzhou Medical University, Guangzhou 510095, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"BDepartment of Dermatology, Guangzhou Institute of Dermatology, 56 Hengfu Road, Guangzhou 510095, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Bi","sequence":"additional","affiliation":[{"name":"AInstitute of Dermatology, Guangzhou Medical University, Guangzhou 510095, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"BDepartment of Dermatology, Guangzhou Institute of Dermatology, 56 Hengfu Road, Guangzhou 510095, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingdong","family":"Ye","sequence":"additional","affiliation":[{"name":"AInstitute of Dermatology, Guangzhou Medical University, Guangzhou 510095, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"BDepartment of Dermatology, Guangzhou Institute of Dermatology, 56 Hengfu Road, Guangzhou 510095, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xibao","family":"Zhang","sequence":"additional","affiliation":[{"name":"AInstitute of Dermatology, Guangzhou Medical University, Guangzhou 510095, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"BDepartment of Dermatology, Guangzhou Institute of Dermatology, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"DCorresponding authors. Email: gzpfbfzs@yahoo.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenling","family":"Cao","sequence":"additional","affiliation":[{"name":"AInstitute of Dermatology, Guangzhou Medical University, Guangzhou 510095, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"BDepartment of Dermatology, Guangzhou Institute of Dermatology, 56 Hengfu Road, Guangzhou 510095, China."},{"name":"DCorresponding authors. Email: gzpfbfzs@yahoo.com"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"2025102615583178900_R1","doi-asserted-by":"crossref","first-page":"20874","DOI":"10.2807\/1560-7917.ES2014.19.30.20862","article-title":"Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.","volume":"19","author":"Golparian","year":"2014","journal-title":"Euro Surveill"},{"key":"2025102615583178900_R2","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill"},{"key":"2025102615583178900_R3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/jac\/dkt017","article-title":"Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.","volume":"68","author":"Chen","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2025102615583178900_R4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/sextrans-2014-051552","article-title":"Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.","volume":"90","author":"van Dam","year":"2014","journal-title":"Sex Transm Infect"},{"key":"2025102615583178900_R5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/jac\/dkv321","article-title":"First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China.","volume":"71","author":"Chen","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2025102615583178900_R6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12879-016-1469-3","article-title":"Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009\u20132013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.","volume":"16","author":"Liang","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2025102615583178900_R7","first-page":"26","article-title":"Clinical and laboratory studies of a new cephalosporin derivative\u2013cefathiamidine.","volume":"92","author":"Tze-ying","year":"1979","journal-title":"Chin Med J (Engl)"},{"key":"2025102615583178900_R8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/00007435-200009000-00011","article-title":"Analysis of the antibiotic sensitivity of Neisseria gonorrhoeae in Guangzhou, Peoples Republic of China.","volume":"27","author":"Wenling","year":"2000","journal-title":"Sex Transm Dis"},{"key":"2025102615583178900_R9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/OLQ.0000000000000218","article-title":"Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated from Guangzhou, China, 2000 to 2005 and 2008 to 2013.","volume":"42","author":"Cao","year":"2015","journal-title":"Sex Transm Dis"},{"unstructured":"World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae (2012). Available online at: http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501\/en\/ [verified 20 March 2016].","key":"2025102615583178900_R10"},{"key":"2025102615583178900_R11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/jac\/dkr021","article-title":"Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone.","volume":"66","author":"Liao","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2025102615583178900_R12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea \u2013 the rapidly evolving Neisseria gonorrhoeae continues to challenge.","volume":"15","author":"Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2025102615583178900_R13","first-page":"590","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025102615583178900_R14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"European STIGEB. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.","volume":"24","author":"Bignell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"2025102615583178900_R15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/14656560902731993","article-title":"The use of cephalosporins for gonorrhea: the impending problem of resistance.","volume":"10","author":"Barry","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"2025102615583178900_R16","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1086\/511422","article-title":"Update on the management of gonorrhea in adults in the United States.","volume":"44","author":"Newman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025102615583178900_R17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s101560170034","article-title":"Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.","volume":"7","author":"Akasaka","year":"2001","journal-title":"J Infect Chemother"},{"key":"2025102615583178900_R18","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1128\/AAC.00198-08","article-title":"Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection.","volume":"52","author":"Lo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2025102615583178900_R19","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"2025102615583178900_R20","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1093\/jac\/dku245","article-title":"Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China.","volume":"69","author":"Chen","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2025102615583178900_R21","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/jac\/dkt543","article-title":"Unique combined penA\/mtrR\/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a \u2018susceptible\u2019 Neisseria gonorrhoeae population.","volume":"69","author":"Thakur","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2025102615583178900_R22","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1074\/jbc.M805761200","article-title":"Crystal structures of penicillin-binding protein 2 from penicillin-susceptible and -resistant strains of Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic resistance.","volume":"284","author":"Powell","year":"2009","journal-title":"J Biol Chem"},{"key":"2025102615583178900_R23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/jac\/dkp505","article-title":"Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.","volume":"65","author":"Lee","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2025102615583178900_R24","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1128\/AAC.01604-06","article-title":"Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.","volume":"51","author":"Lindberg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2025102615583178900_R25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2958.2008.06424.x","article-title":"Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness.","volume":"70","author":"Warner","year":"2008","journal-title":"Mol Microbiol"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/14\/3\/289\/845212\/sh16087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/14\/3\/289\/845212\/sh16087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:58:41Z","timestamp":1761508721000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/14\/3\/289\/106954\/First-four-failures-of-cefathiamidine-to-treat"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6,5]]}},"URL":"https:\/\/doi.org\/10.1071\/sh16087","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"type":"print","value":"1448-5028"},{"type":"electronic","value":"1449-8987"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}